transit lead coverag mckim matt obrien upgrad
share overweight neutral increas pt note
broad-bas physician survey well analysi current system instal
base survey doc variou specialti favor robot confirm
us robot surgeri penetr go much higher analysi
current instal base recent trade-in activ point begin upgrade/new
product cycl older gener fourth gener system togeth see upsid
system placement coupl sustain procedur growth
updat view procedur talk today gener surgeri
bariatr lung etc total differ year believ
best posit enabl shift robot surgeri given larg knowledg base
ecosystem spend recogn premium valuat
believ warrant impact competit hit fundament number
year away upgrade/new product cycl begin
survey point take view innov engin take
technolog variou surgeri futur across spectrum instead survey
gener surgeon doctor growth driver today decid survey variou specialti
neurologist other get viewpoint robot surgeri physician
moreso patient view robot surgeri better tradit approach
expect robot surgeri year penetr half inpati surgic procedur
unit state top area see applic includ bariatr thyroid
gallbladd colon small bowel hernia lung limit interest pharynx liver
heart stomach brain term competitor like disrupt growth
physician answer vote follow verb surgic
rest field smaller pure play
upgrade/new product cycl underway number trade-in aka upgrad
year strong may earli indic upgrad cycl
underway instal base older gener system gener
believ new features/instru xi sp continu drive
trend trade-in activ produc upsid potenti system estim
strateg get mani custom gener system prudent ahead
addit competit like come larger player briefli sp
found two purchas thu far cleveland clinic press releas
payer push back price procedur volum slowdown
make robot system use varieti surgic procedur
ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
upgrad share overweight
thesi chang compani spend hundr million dollar year
 estim view compani continu
grow procedur volum mid-teen year come innov system tool
penetr surgeri updat view procedur talk today
gener surgeri bariatr lung etc total differ year believ
best posit enabl shift robot surgeri given larg knowledg base
ecosystem recogn premium valuat believ warrant impact
competit hit isrg fundament number year away upgrade/new product
cycl begin
transit coverag mckim matt brien upgrad share ow
increas pt base ep estim robot surgeri
penetr rate go much higher see upgrade/new product cycl unfold
prior pt base ep deduct
stock base comp ad isrg cash
take view innov engin take technolog variou
surgeri futur across spectrum instead survey gener surgeon doctor growth
driver today decid survey variou specialti like oncologist famili endocrinologist
ophthalmologist psychiatrist cardiologist neurologist other get viewpoint
robot surgeri exhibit breakdown variou specialti captur
follow specialti best describ
start gener question ask physician robot surgeri wors similar
better tradit approach major believ similar larg group
page
believ better small percent vote wors noth earth
shatter support on-going shift robot show pushback
physician commun say wors overal low view similar
better
adopt robot surgeri grow physician believ robot surgeri
wors similar better outcom tradit surgeri
importantli topic underappreci origin thesi name
patient view robot surgeri wors similar better look rear view prior
neutral thesi lot check hernia especi inguin procedur cost
twice much take twice long thought would lead mediocr adopt
went wrong market robot physician option use
robot ask physician today use inguin respons
includ well dont competitor hospit system lose volum
view goe back key theme within healthcar consum
influenc insight dollar spent shown exhibit believ
robot surgeri produc better outcom mind underestim
shift healthcar goe consum expect robot prefer well
shown chart doctor believ patient view robot surgeri better
compar similar wors
page
physician think patient view robot surgeri wors similar
better tradit approach
key linger question look year robot
surgeri go mani player biggest push back valuat
competit come believ exhibit depict market larg enough
support multipl player also sustain growth next decad
deserv premium valuat view
past state roughli surgic procedur year
last year da vinci account ask divers physician group
goe next year expect continu growth
forese expect half procedur year robot larg number
though continu creat instrument system specif procedur
competit come market differ price point benefit agre penetr
rate go much higher million robot procedur year feel like bit stretch
even robot procedur reach year that still annual compound-annual-growth-rate big
jump even next year stood us procedur compar today
base case acceler procedur growth expect
sustain mid-teen growth forese futur
page
roughli million inpati surgic procedur unit state year
current procedur perform robot see
penetr robot surgeri year scale million
next get procedur growth allud exhibit
frame histor growth robot surgeri ask procedur physician expect
see adopt futur see ask question look exhibit
show adopt today present respond variou procedur
could click like doubl click dislik anyth neutral
robot surgeri strong adopt prostatectomi hysterectomi
recent colorect hernia see robot surgeri grow futur
pleas select area appli
present data sever chart start first like mean one
receiv click physician good lead indic futur growth robot
page
surgeri bariatr receiv follow thyroid gallbladd colon small bowel hernia
lung minim interest pharynx liver heart stomach take top
procedur list annual procedur opportun almost bariatr score
highest increasingli call manag believ introduct
stapler acceler adopt
robot surgeri strong adopt prostatectomi hysterectomi
recent colorect hernia see robot surgeri grow futur
pleas select area appli scale number like
exhibit anoth way show data combin dislik neutral like togeth
percent total procedur interestingli heart brain two
page
robot surgeri strong adopt prostatectomi hysterectomi
recent colorect hernia see robot surgeri grow futur
pleas select area appli
next two exhibit gener question robot surgeri ask physician
benefit robot surgeri exhibit benefit patient exhibit
top three benefit number vote surgeon includ access hard-to-reach-
place enhanc dexter greater visual top three benefit patient includ
smaller incis reduc risk infect shorter hospit faster recoveri
page
greatest benefit robot surgeri physician select appli
greatest benefit robot surgeri patient select appli
lastli ask physician biggest reason adopt robot surgeri
surprisingli cost interestingli enough hospit pushback lowest
seem tie cost much could mean histor percept
robot cost much shown isrg strong system placement continu
hospit adopt mayb less push back administr either way
take variou approach aid cost factor oper leas differ price
point differ system ultim view system price bifurc market larg
page
hard-to-reach placesenhanc dexteritygreat visualizationergonom abil sit consol expand skill set allow new techniqueshospit market attract new patientsnumb incis result reduc risk ofinfectionshort hospit faster recoveri timeminim scarringreduc pain discomfortreduc blood loss transfusionsfew complicationsnumb vote
academ system will pay higher price latest greatest system smaller
hospit system may price sensit need bell whistl
want abl offer robot issu europ seen stronger
uptak platform
biggest concern reason adopt robot surgeri select
final end survey competit question ask pose biggest threat
isrg monopoli one peopl think impact
vote follow verb surgic rest field smaller pure play like
titan medic medrobot cmr auri slightli disagre
respons believ group smaller player impact
respons indic expect competit larger player
page
muchbeliev convent approach goodlack reimbursementincreas setup timelong procedur timeshospit push backnumb vote
intuit surgic da vinci system market leader last decad
robot surgeri new entrant enter market next sever year
think pose biggest threat
number trade-in aka upgrad year strong may earli
indic upgrad cycl underway isrg instal base older gener
system gener believ new features/instru xi sp
continu drive trend trade-in activ expect strong given hospit budget
cycl strateg get mani custom gener system prudent ahead
addit competit like come larger player
briefli sp found two purchas thu far form cleveland clinic press
releas hackensack univers medic press releas
dig deeper system sale instal base trend exhibit show
estim current instal base system si still domin system field
follow xi color code pie chart blue fourth gener system
grey first second third gener system
page
surgic joint ventur googl smaller start-up titan medic medrobot auri cmr exhibit
sourc compani report piper jaffray co estim
look back exhibit show system sale time compani provid
lot detail though estim retir trade-in system interestingli
look old sale peak year launch year then-new si launch
estim si sale peak start top sure trend start slow
year initi launch year then-new xi upgrad
si system climb higher estim
estim alreadi upgrad first half pace
upgrad continu expect upsid system placement throughout
compani report piper jaffray co estim
beyond age instal base believ continu advanc technolog like
enhanc grasper hernia repair vessel sealer extend stapler also contribut
upgrad cycl exhibit look histor trend trade-in retir
system simpl math annual show project result
trend highlight begin upgrad cycl first second
importantli third gener system major si system year old see
reason trend continu go forward
page
trade-in retir system
sourc compani report piper jaffray co estim
take analysi one step believ upsid around system
placement compar model new system placement non-trad in grown
first half assum continu back half year assum
trade-in activ remain strong well total system placement could north
current model use assumpt system placement could
north current model would flow rest revenu build
upsid instrument servic sale well
page
million except per share data
instrument accessori
total revenu
sell gener administr
research develop
incom oper
interest incom expens net
incom tax
non-recur item tax
sg sale
 sale
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
